← All Sponsors
SPONSOR

Shanghai Jiatan Pharmatech Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
NCT05824871 Phase 3
Recruiting

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Rifampin-Resistant Pulmonary Tuberculosis
China View Trial →